Biopol Chemicals Limited
Biopol Chemicals Limited (BIOPOL): company summary
Biopol Chemicals Limited's business has improved significantly, with annual revenue rising 65.2% and net profit growing 106.7% year-on-year.
Biopol Chemicals Limited (BIOPOL) is a micro-cap Chemicals company valued at ₹49 crore operating in Specialty Chemicals on the NSE and BSE.
- Recent price move
- Biopol Chemicals Limited last traded at ₹46, down 2.02% on the day.
- Recent developments
- On 2026-06-30, promoter holding remained at 65.81%, with no significant changes reported. Foreign institutional holding decreased by 4.60 percentage points to 4.70%, and domestic institutional holding fell by 2.38 percentage points to 0.54%. The company has not paid dividends despite reporting profits.
- Financial performance
- Biopol Chemicals Limited's business has improved significantly, with annual revenue rising 65.2% and net profit growing 106.7% year-on-year. However, the latest quarter saw revenue fall 42.5% compared to the same quarter a year earlier, while net profit remained flat at 0.7%. The net profit margin expanded by 2.2 percentage points to 11.1%, and return on equity remained steady at 18.0%.
- Valuation multiples
- The stock trades at 4.3 times earnings, 1.02 times book value.
- Things to watch
- The stock is 61.6% below its 52-week high, indicating a significant drop from recent peak levels. Foreign institutional holding has declined sharply, and domestic institutional holding has also fallen. The company has not distributed any dividends to shareholders despite reporting profits.
- Where it stands
- Biopol Chemicals Limited has shown strong annual growth in revenue and net profit, but the latest quarter's performance was weak. The company's net profit margin has improved, and return on equity remains stable. However, the stock is far below its 52-week high, and institutional holdings have declined.
Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by valuation (9.0) and risk (8.0), but held back by momentum (0.0). Valuation looks strong at 9.0, but that is offset by momentum at 0.0. We are calling it Mixed rather than resolving the conflict for you. Scored on 4 of 5 measures.
DocStoX score
Low confidenceScored on 4 of 5 measures — the rest have no data for this company.
At a glance
Key highlights
- Low leverage — D/E 0.17
- Undemanding at 4× earnings
- Capital works hard — ROCE 23%
- Momentum is weak (0.0/10)
- Near the bottom of its 52-week range (7%)
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Chemicals stocks · Specialty Chemicals
Explore BIOPOL CHEMICALS LIMITED’s valuation
Free deep-dive tools · no sign-up
BIOPOL CHEMICALS LIMITED peers in Chemicals
Other Chemicals stocks on the NSE & BSE. See the full Chemicals sector list.
Related tools & concepts
Value BIOPOL CHEMICALS LIMITED with the ratios and calculators DocStoX uses in its analysis.

